* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : therapeutics;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/actualites/immunoglobulines-sous-cutanees-recommandations-dutilisation-chez-les-patients-atteints-de-pidc-dans-un-contexte-de-tension-dapprovisionnement
2025
false
false
false
France
French
guidelines for drug use
immunoglobulins
injections, subcutaneous
polyradiculoneuropathy, chronic inflammatory demyelinating
immunoglobulins, normal human, for extravascular adm.
immunoglobulins
immunoglobulins

---
https://ansm.sante.fr/tableau-marr/levodopa-carbidopa
2025
false
false
false
France
French
risk management
carbidopa
levodopa
drug combinations
carbidopa, levodopa drug combination
Intestinal Route of Administration
patient care
nursing care
patient care planning
guidelines for drug use
patient education handout
continuity of patient care
patient care management

---
https://ansm.sante.fr/tableau-acces-derogatoire/opdivo-nivolumab-solution-a-diluer-pour-perfusion-yervoy-ipilimumab-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
guidelines for drug use
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
Malignant Pleural Mesothelioma
disease progression
Progressive Neoplastic Disease
infusions, intravenous
continuity of patient care
drug monitoring
carcinoma, non-small-cell lung
melanoma
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIIB Cutaneous Melanoma AJCC v7
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/selpercatinib-20-40-et-80mg-gelule
2025
false
false
false
France
French
selpercatinib
administration, oral
carcinoma, non-small-cell lung
advanced RET fusion-positive non-small cell lung cancer
Product containing only selpercatinib in oral dose form (medicinal product form)
thyroid cancer, medullary
drug information
selpercatinib
pyrazoles
pyridines

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2025
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/alpelisib
2025
false
false
false
France
French
guidelines for drug use
administration, oral
Drug-Related side effects and adverse reactions
alpelisib
Alpelisib
Alpelisib
continuity of patient care
Hyperglycaemic hyperosmolar nonketotic syndrome
hyperglycemia
ketosis
thiazoles
thiazoles

---
https://ansm.sante.fr/tableau-marr/esketamine
2025
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine

---
https://ansm.sante.fr/tableau-marr/fingolimod
2025
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management

---
https://ansm.sante.fr/tableau-atu-rtu/abecma-260-500-x-106-cellules-dispersion-pour-perfusion
2025
false
false
false
France
French
guidelines for drug use
Idecabtagene Vicleucel
Idecabtagene Vicleucel
gene therapy
immunotherapy, adoptive
adult
multiple myeloma
recurrence
Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
Recurrent Multiple Myeloma
genetic therapy

---
https://ansm.sante.fr/tableau-marr/fentanyl-3
2025
false
false
false
France
French
fentanyl
analgesics, opioid
risk management
narcotics
guidelines for drug use
patients guideline
administration, intranasal
nasal sprays
fentanyl
patient education handout

---
https://ansm.sante.fr/tableau-marr/fentanyl-4
2025
false
false
false
France
French
fentanyl
risk management
narcotics
analgesics, opioid
guidelines for drug use
patients guideline
administration, buccal
Orally Disintegrating Film Dosage Form
fentanyl

---
https://ansm.sante.fr/tableau-marr/fentanyl-5
2025
false
false
false
France
French
administration, sublingual
fentanyl
analgesics, opioid
risk management
narcotics
guidelines for drug use
patients guideline
fentanyl
Sublingual Tablet Dosage Form

---
https://ansm.sante.fr/tableau-acces-derogatoire/slenyto
2025
false
false
false
France
French
guidelines for drug use
melatonin
administration, oral
Delayed-Action preparations
child
adolescent
sleep disorders, circadian rhythm
melatonin
rett syndrome
angelman syndrome
tuberous sclerosis
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/arikayce-liposomal
2025
false
false
false
France
French
guidelines for drug use
mycobacterium infections, nontuberculous
amikacin
liposomes
administration, inhalation
pneumonia, bacterial
anti-bacterial agents
Mycobacterium abscessus
amikacin
Infection caused by Mycobacteroides abscessus (disorder)

---
https://ansm.sante.fr/tableau-acces-derogatoire/venclyxto-10-mg-50mg-100-mg-comprimes-pellicules?#
2025
false
false
false
France
French
venetoclax
venetoclax
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
leukemia, myeloid, acute
precursor cell lymphoblastic Leukemia-Lymphoma
Refractory Acute Lymphoblastic Leukemia
Recurrent Acute Lymphoblastic Leukemia
leukemia, lymphocytic, chronic, B-Cell
drug information
Product containing only venetoclax in oral dose form (medicinal product form)
guidelines for drug use
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---
https://publications.msss.gouv.qc.ca/msss/document-001617/
2025
false
false
false
Canada
pneumonia, viral
coronavirus infections
scientific and technical information
Population Forecast
Respect
population
coronavirus, nos
projection
coronavirus
appraiser
homing behavior
projection
population
projection
pandemics
COVID-19

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2025
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/clozapine
2025
false
false
false
France
French
clozapine
risk management
patient education handout
blood cell count
forms
agranulocytosis
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://www.ccne-ethique.fr/fr/publications/enjeux-ethiques-relatifs-la-crise-de-la-psychiatrie-une-alerte-du-ccne
2025
France
public health guidelines
psychiatry
ethical issues
crisis intervention
ethics
crisis, nos
psychiatrist

---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digital-joe
2025
France
health technology assessment
asthma
Pediatricians
pediatrics
pediatrician
asthma
asthma, nos
therapy, nos
digitalis, nos
digitalis
digitalis glycosides

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1414
2025
France
public health guidelines
due to
bone screws
transplants
dengue virus, nos
transplant, nos
human body
dengue virus
judgment
simian immunodeficiency virus
homo sapiens
disease management

---
https://www.cochrane.org/fr/CD012532/CENTRALED_quels-sont-les-benefices-et-les-risques-des-differents-medicaments-dimmunotherapie-pour-traiter-le
2025
United Kingdom
review of literature
french abstract
drug therapy
risk assessment
brain neoplasms
drug, nos
immunotherapy
risks and benefits
immunotherapy, nos
glioblastoma
glioblastoma, nos

---
https://www.has-sante.fr/jcms/p_3586458/fr/kayfanda-odevixibat-traitement-du-prurit-cholestatique-associe-au-syndrome-d-alagille
2025
false
false
false
France
Odevixibat sesquihydrate (substance)
cholestatic pruritus in Alagille syndrome
Cholestatic pruritus (disorder)
infant
child
adult
administration, oral
treatment outcome
insurance, health, reimbursement
odevixibat
evaluation of the transparency committee
pruritus
odevixibat
alagille syndrome

---
https://www.has-sante.fr/jcms/p_3586231/fr/adzynma-adamts13r-purpura-thrombotique-thrombocytopenique-congenital-pttc
2025
false
false
false
France
ADAMTS13 Protein
Apadamtase Alfa
enzyme replacement therapy
congenital thrombotic thrombocytopenic purpura
adult
child
treatment outcome
insurance, health, reimbursement
orphan drug production
injections, intravenous
Congenital thrombotic thrombocytopenic purpura
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic

---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digitale-joe
2025
France
health technology assessment
asthma, nos
digitalis, nos
asthma
therapy, nos
Pediatricians
asthma
digitalis
pediatrician
pediatrics

---
https://www.has-sante.fr/jcms/p_3586461/fr/bifonazole-substipharm-bifonazole-antifongique-topique
2025
false
false
false
France
administration, cutaneous
insurance, health, reimbursement
treatment outcome
bifonazole
adult
adolescent
child
infant
dermatomycoses
tinea
tinea versicolor
candidiasis, cutaneous
candidiasis, chronic mucocutaneous
Mucocutaneous Candidiasis
evaluation of the transparency committee
bifonazole
antifungal agents

---
https://ansm.sante.fr/tableau-marr/sel-de-fer-injectable
2025
false
false
false
France
French
risk management
iron compounds
iron, parenteral preparations
patient education handout
guidelines for drug use
injections, intravenous
infusions, intravenous
iron compounds
anaphylaxis
drug hypersensitivity
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/etrasimod
2025
false
false
false
France
French
risk management
administration, oral
etrasimod
continuity of patient care
guidelines for drug use
patient education handout
pregnancy
patients guideline
Upfront Treatment
Drug Exposure
etrasimod
Etrasimod Arginine

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/tsoludose-solution-buvable-en-recipient-unidose-levothyroxine
2025
false
false
false
France
French
pharmaceutical solutions
administration, oral
levothyroxine sodium
levothyroxine sodium
drug information

---
https://www.has-sante.fr/jcms/p_3556159/fr/dupixent-dupilumab-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
evaluation of the transparency committee
dupilumab
pulmonary disease, chronic obstructive

---
https://ansm.sante.fr/tableau-marr/mavacamten
2025
false
false
false
France
French
risk management
mavacamten
mavacamten
mavacamten
administration, oral
patients guideline
guidelines for drug use
fetus
pregnancy
embryo
drug interactions
heart failure, systolic
Fetal exposure to drug (situation)
Cytochrome P-450 CYP2C19 Inhibitors
Cytochrome P-450 CYP3A4 Inhibitors
Cytochrome P450 family 2 subfamily C member 19 intermediate metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 ultra-rapid metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 normal metabolizer (finding)
patient education handout

---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-diabete-de-type-2-reprise-progressive-des-initiations-de-traitement-pour-ozempic-et-victoza
2025
false
false
false
France
French
patient education handout
guideline
drug information
Glucagon-Like Peptide-1 Receptor Agonists
diabetes mellitus, type 2
Glucagon-like peptide-1 (GLP-1) analogues
Pharmacotherapy Initiation
Pharmacotherapy Continuation
dulaglutide
semaglutide
Liraglutide

---
https://ansm.sante.fr/tableau-acces-derogatoire/avastin-r-25-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
Bevacizumab
drug information
guidelines for drug use
telangiectasia, hereditary hemorrhagic

---
https://www.has-sante.fr/jcms/p_3542801/fr/blincyto-blinatumomab-leucemie-aigue-lymphoblastique
2025
false
false
false
France
blinatumomab
antineoplastic agents
adult
treatment outcome
insurance, health, reimbursement
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Measurable Residual Disease Negativity
consolidation chemotherapy
evaluation of the transparency committee
precursor cell lymphoblastic Leukemia-Lymphoma
blinatumomab

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-disponibilite-de-tsoludose-solution-buvable-en-recipient-unidose
2025
false
false
false
France
French
drug information
thyroxine
levothyroxine sodium
administration, oral
pharmaceutical solutions
patients guideline
guideline

---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline

---
https://ansm.sante.fr/actualites/rifampicine-conduites-a-tenir-dans-un-contexte-de-fortes-tensions-dapprovisionnement
2025
false
false
false
France
French
rifampin
france
administration, oral
infusions, intravenous
guidelines for drug use
antibiotics, antitubercular
-
-
-
osteoarticular infections
tuberculosis
Infection associated with device (disorder)
Infection associated with vascular device (disorder)
Staphylococcal endocarditis (disorder)

---
https://www.has-sante.fr/jcms/p_3445075/fr/experimentation-d-un-indicateur-de-qualite-des-soins-percue-par-les-patients-hospitalises-a-temps-plein-en-psychiatrie
2025
false
false
false
France
technical report
psychiatrist
has patient
inpatients
Full-time Student
Psychiatric Ward Stay
Quality of Care
Inpatient
Full Time Employment
patient care
quality indicators, health care
Patient Care
Indicator
psychiatry
suggestive of
hospital admission, nos
indication of

---
https://ansm.sante.fr/tableau-acces-derogatoire/balversa-erdafitinib
2025
false
false
false
France
French
drug information
erdafitinib
administration, oral
erdafitinib

---
https://ansm.sante.fr/tableau-marr/tafamidis
2025
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2025
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/casgevy
2025
false
false
false
France
French
biological products
exagamglogene autotemcel
Exagamglogene Autotemcel
risk management
beta-Thalassemia
Transfusion Dependent Beta Thalassemia
adolescent
adult
Cell positive for CD34 antigen (cell)
infusions, intravenous
young adult
anemia, sickle cell
drug information

---
https://ansm.sante.fr/tableau-marr/fentanyl-6
2025
false
false
false
France
French
fentanyl
Fentanyl Citrate
risk management
administration, sublingual
guidelines for drug use
fentanyl
patients guideline
adult
breakthrough pain
drug prescriptions
narcotics
Cancer Pain

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-methylphenidate-lansm-publie-des-recommandations-pour-les-pharmaciens
2025
false
false
false
France
French
drug information
guideline
methylphenidate
methylphenidate
patient education handout
administration, oral
drug substitution

---
https://publications.msss.gouv.qc.ca/msss/document-003676/
2025
false
false
false
Canada
guidelines for drug use
Transference
Ambulatory Care Facility
Usage
Clinical Data
Countertransference
Transfer, Psychology
Healthcare Activity
Intervention for Congenital Heart Disease
Clinical Batch
clinical protocols
Healthcare
Clinical Lot
Transfer
nursing
Care
On Study
Clinical Study Protocol
How True Feel Carefree Right Now
Intervention
Transfer Ability
Stooping

---
https://publications.msss.gouv.qc.ca/msss/document-003666/
2025
false
false
false
Canada
handbooks
Clinical Batch
Intervention for Congenital Heart Disease
Clinical Lot
On Study
Usage
primary health care
Clinical Study Protocol
Intervention
Primary Care
nursing
Ambulatory Care Facility
principal
Clinical Data
clinical protocols
primary health care

---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2025
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel

---
https://ansm.sante.fr/tableau-marr/fentanyl-8
2025
false
false
false
France
French
fentanyl
patients guideline
guidelines for drug use
risk management
video recording
guideline
fentanyl

---
https://ansm.sante.fr/tableau-marr/adrenaline
2025
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout
video recording

---
https://www.has-sante.fr/jcms/p_3431851/fr/xenpozyme-olipudase-alfa-deficit-en-sphingomyelinase-acide
2025
false
false
false
France
evaluation of the transparency committee
sphingomyelin/cholesterol lipidosis, nos
xenpozyme
acid, nos
olipudase alfa
niemann-pick diseases
olipudase alfa

---
https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2025
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
graft vs host disease
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease
pharmaceutical solutions
child
guidelines for drug use
summary of product characteristics
package leaflet
tablets

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2025
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2025
false
false
false
France
French
administration, oral
summary of product characteristics
cholangiocarcinoma
guidelines for drug use
leukemia, myeloid, acute
glioma
myelodysplastic syndromes
antineoplastic agents
ivosidenib
ivosidenib
neoplasm metastasis
package leaflet
antineoplastic combined chemotherapy protocols

---
https://www.has-sante.fr/jcms/p_3417653/fr/livtencity-maribavir-infection-a-cmv
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
maribavir
cytomegalovirus infections
antiviral agents
Product containing only maribavir (medicinal product)
adult
organ transplantation
hematopoietic stem cell transplantation
Refractory Cytomegalovirus Infection
administration, oral
evaluation of the transparency committee
maribavir

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2025
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms
defrosting

---
https://ansm.sante.fr/tableau-marr/aflibercept
2025
false
false
false
France
French
guidelines for drug use
patients guideline
aflibercept
recombinant fusion proteins
receptors, vascular endothelial growth factor
Drug-Related side effects and adverse reactions
signs and symptoms
intravitreal injections
video recording
intravitreal injections
sound

---
https://ansm.sante.fr/actualites/amoxicilline-des-recommandations-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2025
false
false
false
France
French
amoxicillin
guidelines for drug use
amoxicillin
administration, oral
infant
child
amoxicillin
amoxicillin-potassium clavulanate combination
amoxicillin-potassium clavulanate combination
amoxicillin and beta-lactamase inhibitor

---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording

---
https://ansm.sante.fr/tableau-marr/apixaban
2025
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2025
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/m-m-rvaxpro-priorix
2025
false
false
false
France
French
vaccination
infant
drug information
measles-mumps-rubella vaccine
Post-Exposure prophylaxis
measles
continuity of patient care
technical report

---
https://ansm.sante.fr/tableau-marr/lauromacrogol-400
2025
false
false
false
France
French
risk management
guidelines for drug use
Polidocanol
polidocanol
patients guideline
Polidocanol
Drug-Related side effects and adverse reactions
continuity of patient care
Polidocanol
drug compounding

---
https://ansm.sante.fr/tableau-acces-derogatoire/teclistamab
2025
false
false
false
France
French
drug information
Teclistamab
adult
multiple myeloma
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
summary of product characteristics
package leaflet
antibodies, monoclonal
Antineoplastic Agents, Immunological
teclistamab

---
https://ansm.sante.fr/tableau-acces-derogatoire/xenpozyme#
2025
false
false
false
France
French
drug information
olipudase alfa
olipudase alfa
enzyme replacement therapy
child
adolescent
adult
niemann-pick diseases

---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local

---
https://ansm.sante.fr/tableau-acces-derogatoire/imfinzi-50-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
durvalumab
guidelines for drug use
Unresectable Biliary Tract Carcinoma
antineoplastic combined chemotherapy protocols
Metastatic Biliary Tract Carcinoma
durvalumab
adult
Cisplatin/Durvalumab/Gemcitabine Regimen
infusions, intravenous
cisplatin
carcinoma, hepatocellular
carcinoma, non-small-cell lung
small cell lung carcinoma
bronchial neoplasms

---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2025
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin
Drug Extravasation
thrombosis

---
https://ansm.sante.fr/tableau-acces-derogatoire/velcade-1-mg-poudre-pour-solution-injectable
2025
false
false
false
France
French
drug information
Bortezomib
injections, intravenous
Immunoglobulin Light-chain Amyloidosis
Non-amyloid monoclonal immunoglobulin deposition disease

---
https://ansm.sante.fr/tableau-acces-derogatoire/xalkori
2025
false
false
false
France
French
drug information
administration, oral
Crizotinib
antineoplastic agents
protein kinase inhibitors
capsules
pharmaceutical solutions
child
infant
lymphoma, large-cell, anaplastic
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
crizotinib
MET Exon 14 Mutation
Locally Advanced Lung Non-Small Cell Carcinoma
adult
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
continuity of patient care

---
https://ansm.sante.fr/tableau-marr/cladribine
2025
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2025
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-acces-derogatoire/imcivree#
2025
false
false
false
France
French
setmelanotide
adult
adolescent
child
obesity
obesity
bardet-biedl syndrome
continuity of patient care
drug monitoring
product surveillance, postmarketing
setmelanotide
injections, subcutaneous
guidelines for drug use
package leaflet
summary of product characteristics
technical report

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/imogam-rage-150-ui-ml-solution-injectable-immunoglobuline-humaine-rabique
2025
false
false
false
France
French
drug information
rabies vaccines
rabies
Human Rabies Virus Immune Globulin
vaccination
rabies immunoglobulin
Post-Exposure prophylaxis
Drug Recalls

---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2025
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information

---
https://ansm.sante.fr/tableau-acces-derogatoire/thalidomide-bms-50-mg-gelule
2025
false
false
false
France
French
guidelines for drug use
continuity of patient care
thalidomide
administration, oral
Jessner lymphocytic infiltration of the skin
lupus erythematosus, cutaneous
stomatitis, aphthous
Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)
crohn disease
erythema multiforme
Erythema multiforme major
technical report

---
https://ansm.sante.fr/tableau-acces-derogatoire/lutathera
2025
false
false
false
France
French
infusions, intravenous
drug information
lutetium (177Lu) oxodotreotide
lutetium Lu 177 dotatate
radiopharmaceuticals
guidelines for drug use
Pheochromocytoma-paraganglioma
pheochromocytoma
Metastatic Lung Neuroendocrine Tumor
bronchial neoplasms
neoplasm metastasis
Thymic neuroendocrine tumor
neuroendocrine tumors
thymus neoplasms
Metastatic Thymus Neuroendocrine Neoplasm
meningioma
Somatostatin Receptor Positive
Somatostatin Receptor 2 Positive
technical report

---
https://ansm.sante.fr/tableau-marr/adrenaline-3
2025
false
false
false
France
French
risk management
epinephrine
guidelines for drug use
self administration
injections, intramuscular
epinephrine
anaphylaxis
patients guideline
drug storage
video recording
epinephrine

---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2025
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain

---
https://ansm.sante.fr/tableau-marr/etonogestrel
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins
Migration of implanted drug
Surveillance of subcutaneous contraceptive implant (regime/therapy)

---
https://ansm.sante.fr/tableau-marr/icodextrine
2025
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin
Blood glucose meter (physical object)
directory
patient education handout

---
https://www.has-sante.fr/jcms/p_3589534/fr/skyclarys-omaveloxolone-traitement-de-l-ataxie-de-friedreich-af
2025
false
false
false
France
omaveloxolone
evaluation of the transparency committee
friedreich's ataxia
Omaveloxolone
Omaveloxolone
friedreich ataxia

---
https://ansm.sante.fr/tableau-marr/ranibizumab-4
2025
false
false
false
France
French
drug information
patient education handout
risk management
Ranibizumab
Drug-Related side effects and adverse reactions
eye diseases
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
intravitreal injections
ranibizumab

---
https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-referentiel-organisatio
https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-synthese
2025
false
false
false
France
guideline
drug therapy
hospitals
administration of therapeutic substance, nos
antineoplastic agents
hematology
patients
day care center
hospital, nos
has patient
hospitalization
injections
Oncologists

---
https://www.cancer.fr/catalogue-des-publications/traitements-de-1re-ligne-du-cbnpc-metastatique-sans-addiction-oncogenique-synthese
https://www.cancer.fr/catalogue-des-publications/traitements-de-1re-ligne-du-cbnpc-metastatique-sans-addiction-oncogenique-thesaurus
2025
false
false
false
France
guideline
carcinoma, non-small-cell lung
behavior, addictive
oncogenes
oncogene
dependent drug abuse
fracture fixation
Cloud Computing

---
https://ansm.sante.fr/actualites/heparine-calcique-en-seringue-preremplie-tensions-dapprovisionnement-et-arret-de-commercialisation
2025
false
false
false
France
French
drug information
guideline
calcium heparin
injections, subcutaneous
Pre-filled Syringe
heparin
patients guideline
anticoagulants

---
https://ansm.sante.fr/tableau-marr/denosumab-1
2025
false
false
false
France
French
risk management
Denosumab
denosumab
Drug-Related side effects and adverse reactions
patient education handout
drug information
osteonecrosis
jaw diseases
Osteonecrosis of Jaw

---
https://www.cochrane.org/fr/CD015790/CENTRALED_les-programmes-dautogestion-peuvent-ils-ameliorer-la-qualite-de-vie-des-adultes-malvoyants
2025
United Kingdom
review of literature
french abstract
Program
Persons with Visual Disabilities
self care
quality of life
adult
adulthood
quality improvement

---
https://www.has-sante.fr/jcms/p_3588817/fr/iqirvo-elafibranor-cholangite-biliaire-primitive
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
Primary Biliary Cholangitis
drug therapy, combination
ursodeoxycholic acid
adult
elafibranor
evaluation of the transparency committee
elafibranor

---
https://www.has-sante.fr/jcms/p_3586972/fr/alber-scalamobil-s45
2025
France
health technology assessment
rehabilitation
habilitation
Stair Climbing
carrying
lifting
adaptation, nos
wheel chair, nos
transportation
wheelchairs
Textbook

---
https://www.has-sante.fr/jcms/p_3589751/fr/agilus-dantrolene-sodique-hemiheptahydrate-anesthesie
2025
false
false
false
France
Dantrolene sodium, hemiheptahydrate
insurance, health, reimbursement
treatment outcome
adult
child
adolescent
Malignant hyperpyrexia caused by anesthetic (disorder)
anesthetics
malignant hyperthermia
infant
dantrolene
Product containing only dantrolene in parenteral dose form (medicinal product form)
evaluation of the transparency committee
Dantrolene Sodium
dantrolene

---
https://www.has-sante.fr/jcms/p_3589935/fr/kinox-monoxyde-d-azote-vasodilatateur-inhale
2025
false
false
false
France
adult
infant, newborn
adolescent
child
infant
nitric oxide
perioperative pulmonary hypertension
postoperative pulmonary hypertension
cardiac surgical procedures
evaluation of the transparency committee
nitric oxide
administration, inhalation
hypertension, pulmonary
respiratory distress syndrome, newborn

---
https://www.has-sante.fr/jcms/p_3590025/fr/sam-de-l-ansm-sur-le-tramadol-modification-des-conditions-de-prescription-et-de-delivrance-cpd-afin-de-reduire-le-risque-de-mesusage-d-addiction-et-de-surdosage
2025
France
algorithms
operations research
macrophage activation syndrome
indexing
Abstracting and Indexing
mosaic variegated aneuploidy syndrome
drug overdose, nos
behavior, addictive
decision support techniques
delivery, obstetric
risk
prescription, nos
drug overdose
tramadol
dependent drug abuse

---
https://www.has-sante.fr/jcms/p_3590117/fr/vaccin-antigrippal-vaxigrip-transition-du-vaccin-antigrippal-vaxigrip-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
influenza vaccination
health planning guidelines
vaxigrip
vaccinia virus vaccine
influenza
influenza, human
influenza virus vaccine
influenza vaccines
vaccination
vaccination
preventive immunization/medication
due to
vaxigrip
influenza A virus

---
https://www.has-sante.fr/jcms/p_3590911/fr/glucose-aguettant-glucose-solute
2025
false
false
false
France
infusions, intravenous
insurance, health, reimbursement
treatment outcome
carbohydrates
evaluation of the transparency committee
glucose

---
https://www.has-sante.fr/jcms/p_3590636/fr/imfinzi-durvalumab-cancer-de-l-endometre
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
durvalumab
antineoplastic combined chemotherapy protocols
Mismatch Repair Deficiency
adult
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
neoplasm recurrence, local
infusions, intravenous
evaluation of the transparency committee
durvalumab
endometrial neoplasms

---
https://www.has-sante.fr/jcms/p_3591345/fr/relistor-bromure-de-methylnaltrexone-constipation-liee-aux-opioides
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
methylnaltrexone bromide
injections, subcutaneous
adult
evaluation of the transparency committee
Opioid-Induced Constipation
methylnaltrexone
naltrexone methylbromide

---
https://www.has-sante.fr/jcms/p_3590639/fr/imfinzi-lynparza-durvalumab/olaparib-cancer-de-l-endometre
2025
false
false
false
France
antineoplastic combined chemotherapy protocols
insurance, health, reimbursement
treatment outcome
Antineoplastic Agents, Immunological
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
Mismatch Repair Proficient
Mismatch Repair Deficiency
durvalumab
durvalumab
olaparib
olaparib
evaluation of the transparency committee
endometrial neoplasms

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/elvorine-25-mg-2-5-ml-50-mg-5-ml-100-mg-10-ml-et-175-mg-17-5-ml-solution-injectable-levofolinate-de-calcium
2025
false
false
false
France
French
drug information
leucovorin, calcium (1:1) salt, (S)-Isomer
levoleucovorin

---
https://ansm.sante.fr/tableau-marr/tolcapone
2025
false
false
false
France
French
risk management
continuity of patient care
Chemical and Drug Induced Liver Injury
neuroleptic malignant syndrome
Tolcapone
tolcapone
liver function tests
drug information
patient education handout

---
https://ansm.sante.fr/tableau-marr/tremelimumab
2025
false
false
false
France
French
tremelimumab
tremelimumab
risk management
drug information
patient education handout
Immune-Mediated Adverse Reaction
Drug-Related side effects and adverse reactions
signs and symptoms
Drug-Related side effects and adverse reactions

---
https://minerva-ebp.be/Theme/Analysis/891
2025
Belgium
critical appraisal or critical reading
patient care management
pharmacology
pharmacologist
drug therapy
panic
panic disorder

---
https://www.cancer.fr/presse/renforcer-la-securisation-medicamenteuse-des-patients-sous-anticancereux-injectables
2025
France
guideline
antineoplastic agents
injections
patients
hospitalization
drug therapy
hospital, nos
day care center
has patient
hospitals
administration of therapeutic substance, nos

---
https://www.cochrane.org/fr/CD013722/CENTRALED_quels-sont-les-effets-des-interventions-sur-les-ventes-de-medicaments-antimicrobiens-sans-ordonnance
2025
United Kingdom
review of literature
french abstract
community pharmacies
microbicides
nonprescription drugs
prescription drugs
prescription drug, nos
drug action, nos
sales
pharmacies
anti-infective agents

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-therapies-bispecifiques-et-therapies-par-lymphocytes-t-infiltrant-la-tumeur-considerations-pour-un-deploiement-au-quebec.html
2025
Canada
health technology assessment
quebec
neoplasms
therapy, nos
lymphocytes, tumor-infiltrating
t lymphocyte
T-Lymphocytes
infiltration, nos

---
https://cngof.fr/app/pdf/RPC//RPC%20DU%20CNGOF/Gyn%C3%A9cologie/Oncologie/Reco%20depistage%20col%20GOFS%202025.pdf?x60010
2025
France
consensus
dermatomyositis
screening
health planning guidelines
disease management
women
uterus, nos
viral disease other/nos
papillomaviridae
cell biology
Cytology
female
abnormal behavior, nos
mass screening

---
https://www.calameo.com/onco-occitanie/read/00717809236de148a34fb
2025
France
scientific and technical information
drug therapy
neoplasms
drug, nos
cancer
home care services, hospital-based
neoplasm, malignant

---
https://www.cfp.ca/content/71/2/105
2025
Canada
journal article
with cleaniless
prepuce of penis
hygiene
complication, nos
nursing
patient care management
foreskin

---
https://www.has-sante.fr/jcms/p_3590908/fr/chlorure-de-sodium-aguettant-chlorure-de-sodium-solute
2025
false
false
false
France
evaluation of the transparency committee
solutions
urine chloride
sodium chloride
sodium chloride
solution, nos

---
https://www.has-sante.fr/jcms/p_3592928/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine-avec-cardiomyopathie
2025
false
false
false
France
amyloid neuropathies, familial
evaluation of the transparency committee
amylose
amyloidosis, hereditary, Transthyretin-Related
cardiomyopathies

---
https://publications.msss.gouv.qc.ca/msss/document-003869/
2025
Canada
handbooks
antineoplastic agents
route of administration, nos
administration
injections, intramuscular
nursing care
nursing care, nos
nurse administrators
subcutaneous tissue, nos
protestantism
antineoplastic agent, nos

---
https://www.chu-lyon.fr/etp-lift-liyon-foie-transition
2025
France
patient education handout
Bridge Therapy
chronic disease
disease of liver, nos
education
liver
has patient
disease
chronic disease, nos
liver diseases
patient education as topic

---
https://www.reiso.org/articles/themes/pratiques/13536-des-presences-actives-recette-du-vivre-ensemble
2025
Switzerland
journal article
activir
recipes
activator appliances

---
http://beh.santepubliquefrance.fr/beh/2025/1/2025_1_1.html
2025
France
journal article
appraiser
Vaccination Coverage
Balance Sheet
school health services
Respect
scales
weights and measures
ladder, nos
health
feasibility studies
due to

---
https://www.calameo.com/onco-occitanie/read/0071780926f9da30c68d6
2025
France
guideline
drug, nos
home care services, hospital-based
drug therapy
cancer
neoplasms
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3575020/fr/tecartus-brexucabtagene-autoleucel-lymphome-a-cellules-du-manteau-lcm
2025
false
false
false
France
evaluation of the transparency committee
antigens, CD19
"u" lymphocyte
brexucabtagene autoleucel
brexucabtagene autoleucel
cells

---
https://www.has-sante.fr/jcms/p_3576495/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
Generalized pustular psoriasis
Generalized pustular psoriasis flare
spesolimab
adult
adolescent
evaluation of the transparency committee
psoriasis
spesolimab

---
https://www.has-sante.fr/jcms/p_3574834/fr/tibsovo-ivosidenib-cancer-voies-biliaires
2025
false
false
false
France
locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation
evaluation of the transparency committee
ivosidenib
ivosidenib
biliary tract, nos
neoplasm, malignant
Tibsovo
biliary tract neoplasms
biliary tract cancer

---
https://www.has-sante.fr/jcms/p_3576108/fr/adzynma-apadamtase-alfa-purpura-thrombotique-thrombocytopenique-congenital-pttc-pediatrie
2025
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
Apadamtase Alfa
guidelines for drug use
apadamtase alfa and cinaxadamtase alfa
Cinaxadamtase Alfa
enzyme replacement therapy
ADAMTS13 protein, human
injections, intravenous
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic
congenital thrombotic thrombocytopenic purpura

---
https://www.has-sante.fr/jcms/p_3508311/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept

---
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet

---
https://www.has-sante.fr/jcms/p_3574058/fr/transition-du-vaccin-antigrippal-influvac-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
influenza virus vaccine
influenza
influvac
preventive immunization/medication
vaccination
influenza vaccination
influenza, human
health planning guidelines
vaccination
influenza vaccines
influvac
due to

---
https://www.has-sante.fr/jcms/p_3574297/fr/developpement-d-un-indicateur-de-qualite-des-soins-percue-par-les-patients-pris-en-charge-dans-une-structure-des-urgences
2025
France
technical report
indication of
emergency treatment
case management
quality indicators, health care
suggestive of
has patient
emergencies
patient care

---
https://www.has-sante.fr/jcms/p_3576200/fr/iqirvo-elafibranor-cholangite-biliaire-primitive-cbp
2025
false
false
false
France
drug therapy, combination
evaluation of the transparency committee
cholangitis
elafibranor
Primary Biliary Cholangitis

---
https://www.has-sante.fr/jcms/p_3576557/fr/vyloy-zolbetuximab-adenocarcinome-gastrique-et-de-la-jonction-oesogastrique
2025
false
false
false
France
antineoplastic combined chemotherapy protocols
treatment outcome
insurance, health, reimbursement
adult
Fluoropyrimidine
platinum salt, nos
Gastric Adenocarcinoma
stomach neoplasms
Gastroesophageal Junction Adenocarcinoma
esophageal neoplasms
HER2/Neu Negative
CLDN18.2 Positive
infusions, intravenous
zolbetuximab
evaluation of the transparency committee
zolbetuximab
adenocarcinoma

---
https://www.has-sante.fr/jcms/p_3576426/fr/viperfav-fragment-f-ab-2-d-immunoglobulines-equines-antivenimeuses-de-viperes-europeennes-vipera-aspis-vipera-berus-vipera-ammodytes-immunoglobulines
2025
false
false
false
France
immunoglobulin fab fragments
treatment outcome
insurance, health, reimbursement
snake venom antiserum
snake bites
Snakebite envenomation
infusions, intravenous
evaluation of the transparency committee
european viper

---
https://www.has-sante.fr/jcms/p_3577027/fr/nomanesit-sumatriptan/naproxene-migraine
2025
false
false
false
France
sumatriptan-naproxen
sumatriptan succinate
naproxen sodium
administration, oral
insurance, health, reimbursement
treatment outcome
migraine without aura
sumatriptan and naproxen
adult
drug combinations
evaluation of the transparency committee
migraine with aura

---
https://www.has-sante.fr/jcms/p_3577030/fr/benlysta-belimumab-lupus-systemique-actif
2025
false
false
false
France
belimumab
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
belimumab

---
https://www.has-sante.fr/jcms/p_3574253/fr/ventoline-salbutamol-asthme
2025
false
false
false
France
injections, subcutaneous
acute disease
evaluation of the transparency committee
albuterol
asthma

---
https://www.has-sante.fr/jcms/p_3576262/fr/jakavi-ruxolitinib-maladie-du-greffon-pediatrie
2025
false
false
false
France
administration, oral
pharmaceutical solutions
graft vs host disease
child
ruxolitinib
Janus Kinase Inhibitors
evaluation of the transparency committee
ruxolitinib

---
https://www.has-sante.fr/jcms/p_3577036/fr/kalydeco-ivacaftor-mucoviscidose
2025
false
false
false
France
infant
treatment outcome
insurance, health, reimbursement
administration, oral
ivacaftor
evaluation of the transparency committee
cystic fibrosis
ivacaftor

---
https://www.has-sante.fr/jcms/p_3576423/fr/pheburane-phenylbutyrate-de-sodium-desordres-du-cycle-de-l-uree
2025
false
false
false
France
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
sodium phenylbutyrate
4-phenylbutyric acid
carbamoyl-phosphate synthase i deficiency disease
citrullinemia
ornithine carbamoyltransferase deficiency disease
evaluation of the transparency committee
phenylbutyrates
4-phenylbutyric acid, sodium salt

---
https://www.inspq.qc.ca/publications/3606
2025
Canada
technical report
data collection
pain
symptom, nos
anxiety
sleep disorder, nos
pain, nos
anxiety disorders
Sleep Wake Disorders
self care
anxious mood
anxiety
cannabis, nos
syndrome
cannabis
sleep disorders

---
https://www.ofdt.fr/actualite/drogues-et-addictions-chiffres-cles-2025-2473
2025
France
journal article
dependent drug abuse
behavior, addictive
drugged state
drug addicts
substance-related disorders

---
https://ansm.sante.fr/tableau-marr/denosumab
2025
false
false
false
France
French
risk management
Denosumab
patient education handout
drug information
osteonecrosis
Osteonecrosis of Jaw

---
https://www.academie-medecine.fr/attention-au-contact-etroit-des-enfants-au-domicile-avec-des-animaux-de-compagnie-non-traditionnels-acnt-2/
2025
France
scientific and technical information
preventive treatment, nos
fibrosis, nos
secondary prevention
fibrosis
early therapy
early diagnosis
no diagnosis
kidney, nos

---
https://www.chu-lyon.fr/mesures-conduites-tenir-urgence-main
2025
France
popular works
disease management
snacks
first aid
weights and measures
hand
measures
emergencies

---
https://www.has-sante.fr/jcms/p_3578491/fr/jemperli-dostarlimab-cancer-de-l-endometre
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
dostarlimab
antineoplastic combined chemotherapy protocols
Carboplatin/Dostarlimab/Paclitaxel Regimen
carboplatin
paclitaxel
Mismatch Repair Deficiency
High-Frequency Microsatellite Instability
adult
infusions, intravenous
antineoplastic agents
evaluation of the transparency committee
dostarlimab
endometrial neoplasms

---
https://www.has-sante.fr/jcms/p_3579042/fr/prise-en-charge-de-la-maladie-de-coats
2025
France
practice guideline
exudative retinopathy
chronic disease, nos
chronic disease
retinal telangiectasis
Handbook
disease management

---
https://www.sfed.org/wp-content/uploads/2025/01/SFED-Recommandations-Preparation-Coloscopie-adaptation-des-recommandations-de-lESGE-2019.pdf
2025
France
guideline
health planning guidelines
adaptation, nos
colonoscopy
rehabilitation
habilitation

---
https://aims.univ-rouen.fr/
false
false
false
France
Precision Medicine
One Health
medical informatics
research structure

---
https://www.cmg.fr/wp-content/uploads/2025/01/Accueil-et-prise-en-charge-des-personnes-en-situation-de-surpoids-ou-dobesite-CMG-20240425.pdf
2025
France
guideline
Obesity Management
overweight
obesity
obesity, nos
persons

---
https://www.has-sante.fr/jcms/p_3585759/fr/balversa-erdafitinib-carcinome-urothelial
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
erdafitinib
Product containing only erdafitinib in oral dose form (medicinal product form)
administration, oral
FGFR Inhibitor
receptors, fibroblast growth factor
adult
Unresectable Urothelial Carcinoma
Metastatic Urothelial Carcinoma
FGFR3 Gene Alteration Positive
receptor, fibroblast growth factor, type 3
Alteration of genetic material (finding)
evaluation of the transparency committee
Balversa
erdafitinib

---
https://www.has-sante.fr/jcms/p_3585496/fr/cosidime-dorzolamide-/-timolol
2025
false
false
false
France
dorzolamide hydrochloride-timolol maleate combination
timolol maleate
drug combinations
treatment outcome
insurance, health, reimbursement
glaucoma, open-angle
timolol, combinations
administration, ophthalmic
dorzolamide
evaluation of the transparency committee
dorzolamide hydrochloride
timolol
dorzolamide-timolol combination

---
https://www.sfed.org/wp-content/uploads/2025/01/SFED-Preparation-Coloscopie-adaptation-des-recommandations-de-lESGE-2019.pdf
2025
France
guideline
health planning guidelines
adaptation, nos
habilitation
colonoscopy
rehabilitation

---
https://www.inspq.qc.ca/publications/3633
2025
Canada
technical report
quebec
organization and administration
Infections
Vancomycin-Resistant Enterococci
resistance to infection, nos
vancomycin

---
https://www.academie-medecine.fr/traitement-des-cancers-solides-par-therapies-cellulaires-un-espoir-qui-se-concretise/
2025
France
scientific and technical information
cell therapy
cell- and Tissue-Based therapy
hope
cell, nos
therapy, nos

---
https://www.canal-u.tv/chaines/mediamed/la-musicotherapie-et-l-impossible-consolation-par-maratuech-camille
2025
France
audiovisual aids
music therapy

---
https://www.has-sante.fr/jcms/p_3598812/fr/nordimet-methotrexate-psoriasis-en-plaque-modere
2025
false
false
false
France
adult
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
methotrexate
evaluation of the transparency committee
psoriasis
methotrexate

---
https://www.inrs.fr/media.html?refINRS=QR+185
2025
France
journal article
rehabilitation
work
occupation, nos
rescue work
first aid

---
https://ansm.sante.fr/tableau-marr/etranacogene-dezaparvovec
2025
false
false
false
France
French
risk management
Etranacogene Dezaparvovec
etranacogene dezaparvovec
guidelines for drug use
patients guideline
popular works
thromboembolism
Drug-Related side effects and adverse reactions
Chemical and Drug Induced Liver Injury
gene therapy
Gene Therapy Agents
semen
blood
DNA-Mediated Gene Transfer
pregnancy
gene transfer, horizontal

---
https://publications.msss.gouv.qc.ca/msss/document-003875/
2025
Canada
handbooks
hypersensitivity
tool, nos
therapy, nos

---
https://www.has-sante.fr/jcms/p_3599233/fr/champix-tartrate-de-varenicline-sevrage-tabagique
2025
false
false
false
France
evaluation of the transparency committee
weaning
smoking cessation
Varenicline
champix
varenicline tartrate
tobacco use cessation

---
https://ansm.sante.fr/actualites/clozapine-une-prescription-initiale-desormais-possible-en-ville
2025
false
false
false
France
French
urban health services
drug prescriptions
Upfront Treatment
clozapine
antipsychotic agents
clozapine
drug information
legislation, pharmacy

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-sertraline-mesures-et-recommandations-pour-assurer-la-continuite-des-traitements
2025
false
false
false
France
French
sertraline
antidepressive agents
sertraline
drug information
Selective Serotonin Reuptake Inhibitors
guideline
continuity of patient care

---
https://www.ema.europa.eu/en/medicines/human/EPAR/yesintek
2025
false
false
false
Netherlands
French
English
Ustekinumab
Ustekinumab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals
drug approval
europe

---
https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
3,3',5-triiodothyroacetic acid
3,3',5-triiodothyroacetic acid
orphan drug production
tiratricol
drug approval
europe
triiodothyronine
thyrotoxicosis
Allan-Herndon-Dudley Syndrome
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/eribulin-baxter
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
eribulin mesylate
eribulin mesylate
drugs, generic

---
https://www.ema.europa.eu/en/medicines/human/EPAR/apexelsin
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
paclitaxel
paclitaxel

---
https://www.ema.europa.eu/en/medicines/human/EPAR/winrevair
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
sotatercept
sotatercept
orphan drug production
sotatercept
hypertension, pulmonary
injections, subcutaneous
drug approval
europe
adult
drug therapy, combination
activins
risk management
pregnancy
breast feeding
aged
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/balversa
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
erdafitinib
erdafitinib
erdafitinib
drug approval
europe
Balversa
Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma
urologic neoplasms
adult
urologic neoplasms
FGFR3 Gene Alteration Positive
administration, oral
continuity of patient care
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
FGFR Inhibitor
FGFR Inhibitor
risk management
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
antineoplastic agents
antineoplastic agents
drug evaluation, preclinical

---
https://www.cochrane.org/fr/CD006606/CENTRALED_quelle-est-la-meilleure-therapie-pour-les-femmes-qui-produisent-trop-dovules-lorsquelles-suivent-un
2025
United Kingdom
review of literature
french abstract
women
infertility
infertility, nos
ovum
therapy, nos

---
https://www.ema.europa.eu/en/medicines/human/EPAR/anzupgo
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
delgocitinib
delgocitinib
drug approval
europe
delgocitinib
hand dermatoses
eczema
chronic disease
Chronic hand eczema (disorder)
adult
administration, cutaneous
Janus Kinase Inhibitors
Janus Kinase Inhibitors
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vyloy
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
zolbetuximab
zolbetuximab
orphan drug production
zolbetuximab
drug approval
europe
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
infusions, intravenous
antibodies, monoclonal
antibodies, monoclonal
stomach neoplasms
esophageal neoplasms
adenocarcinoma
antineoplastic combined chemotherapy protocols
Metastatic Gastric Adenocarcinoma
Locally Advanced Unresectable Gastric Adenocarcinoma
Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
CLDN18.2 Positive
HER2/Neu Negative
product surveillance, postmarketing
adult
aged
CLDN18 protein, human
Anti-claudin18.2 Monoclonal Antibody
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/kayfanda
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
odevixibat
odevixibat
odevixibat
drug approval
europe
child
infant
cholestatic pruritus in Alagille syndrome
alagille syndrome
pruritus
Cholestatic pruritus (disorder)
administration, oral
Sprinkle Capsule Dosage Form
Ileal Bile Acid Transport Inhibitor
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.ema.europa.eu/en/medicines/human/EPAR/iqirvo
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
administration, oral
elafibranor
elafibranor
orphan drug production
drug approval
europe
adult
Primary Biliary Cholangitis
drug therapy, combination
ursodeoxycholic acid
elafibranor
Peroxisome Proliferator-Activated Receptor Agonist
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
PPAR alpha
PPAR delta
drug evaluation, preclinical

---
Fluenz - influenza vaccine (live attenuated, nasal)
https://www.ema.europa.eu/en/medicines/human/EPAR/fluenz
2025
false
false
false
France
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
influenza, human
influenza vaccines
vaccination
Trivalent Live-Attenuated Influenza Vaccine

---
https://minerva-ebp.be/FR/Article/2429
2025
Belgium
critical appraisal or critical reading
exercise
manual therapies
musculoskeletal manipulations
tennis elbow
epicondylitis, nos
therapy, nos

---
https://www.has-sante.fr/jcms/p_3599701/fr/beclometasone-formoterol-biogaran-beclometasone-/-formoterol-asthme-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, inhalation
formoterol and beclometasone
evaluation of the transparency committee
asthma
beclomethasone
pulmonary disease, chronic obstructive
Formoterol Fumarate

---
https://www.has-sante.fr/jcms/p_3599704/fr/ferrostrane-nourrissons-feredetate-de-sodium-carence-martiale
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
pharmaceutical solutions
administration, oral
sodium feredetate
evaluation of the transparency committee
Iron Deficiencies
ferric sodium edetate
infant
Fe(III)-EDTA

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/nouveaux-traitements-medicamenteux-pour-la-maladie-dalzheimer-considerations-pour-la-prise-en-charge-des-patients.html
2025
Canada
review of literature
drug, nos
has patient
drug therapy
case management
alzheimer disease
alzheimer's disease, nos

---
https://www.has-sante.fr/jcms/p_3600306/fr/fluenz-vaccin-grippal-trivalent-vivant-attenue-nasal-vaccin-antigrippal
2025
France
evaluation of the transparency committee
influenza vaccines
vaccination
vaccines, attenuated
preventive immunization/medication
attenuated by
nose, nos
influenza virus vaccine

---
https://www.has-sante.fr/jcms/p_3601437/fr/beovu-brolucizumab-degenerescence-maculaire-liee-a-l-age-dmla-oedeme-maculaire-diabetique-omd
2025
France
evaluation of the transparency committee
macular degeneration
degeneration, nos
brolucizumab
diabetes mellitus
age, nos
macular degeneration
macule, nos
brolucizumab
macular edema
edema, nos

---
https://www.has-sante.fr/jcms/p_3601428/fr/kisqali-ribociclib-cancer-du-sein
2025
false
false
false
France
treatment outcome
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
evaluation of the transparency committee
neoplasm, malignant
Kisqali
breast cancer
ribociclib
breast neoplasms
ribociclib

---
https://www.has-sante.fr/jcms/p_3601303/fr/edurant-rilpivirine-vih
2025
false
false
false
France
child
adult
evaluation of the transparency committee
human immunodeficiency virus, nos
Rilpivirine
hiv infections

---
https://ansm.sante.fr/actualites/decision-du-11-04-2025-portant-modification-au-registre-des-groupes-hybrides-mentionne-a-larticle-l-5121-10-du-code-de-la-sante-publique
2025
false
false
false
France
French
drug information

---
https://www.has-sante.fr/jcms/p_3587072/fr/krazati-adagrasib-cancer-bronchique-non-a-petites-cellules
2025
false
false
false
France
adagrasib
KRAS NP_004976.2:p.G12C
KRAS Gene Mutation
evaluation of the transparency committee
adagrasib
carcinoma, non-small-cell lung

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-traitement-pharmacologique-visant-lelimination-fecale-chez-une-personne-qui-recoit-des-soins-palliatifs-ou-qui-presente-un-profil-geriatrique.html
2025
Canada
guideline
Geriatricians
geriatrics
pharmacology
palliative care, nos
persons
pharmacologist
feces
drug therapy
palliative care

---
https://www.ordre.pharmacien.fr/les-communications/focus-sur/les-autres-publications/les-tutos-de-h-renouvellement-et-adaptation-des-prescriptions-en-pui
2025
France
audiovisual aids
renewal of prescription
habilitation
adaptation, nos
pharmacy service, hospital
rehabilitation

---
https://www.santepubliquefrance.fr/determinants-de-sante/pollution-et-sante/air/documents/enquetes-etudes/estimation-de-la-morbidite-attribuable-a-l-exposition-a-long-terme-a-la-pollution-de-l-air-ambiant-et-de-ses-impacts-economiques-en-france-hexagona
2025
France
technical report
appraiser
Respect
morbidity
french
air pollution
air pollution
cost savings
quantitative evaluation
evaluation studies as topic
Exhibition
air pollution, indoor
exposure to pollution, nos
economics
france
health impact assessment

---
https://www.santepubliquefrance.fr/determinants-de-sante/pollution-et-sante/air/documents/enquetes-etudes/estimation-de-la-morbidite-attribuable-a-l-exposition-a-long-terme-a-la-pollution-de-l-air-ambiant-et-de-ses-impacts-economiques-en-france-hexagona2
2025
France
technical report
Economic Evaluation
france
Exhibition
air pollution
exposure to pollution, nos
french
air pollution
costs and cost analysis
appraiser
air pollution, indoor
Respect
morbidity

---
https://www.santepubliquefrance.fr/regions/auvergne-rhone-alpes/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-auvergne-rhone-alpes
2025
France
technical report
Air Quality
quality improvement
health
appraiser
air, nos
Respect
air pollution, indoor

---
https://www.santepubliquefrance.fr/regions/bourgogne-franche-comte/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-bourgogne-franche-comte
2025
France
technical report
air, nos
air pollution, indoor
quality improvement
health
Air Quality
Respect
appraiser

---
https://www.santepubliquefrance.fr/regions/bretagne/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-bretagne
2025
France
technical report
health
appraiser
Respect
air pollution, indoor
air, nos
quality improvement
Air Quality

---
https://www.santepubliquefrance.fr/regions/centre-val-de-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-centre-val-de-loire
2025
France
technical report
Air Quality
quality improvement
air, nos
Respect
air pollution, indoor
health
central
valine
appraiser

---
https://www.santepubliquefrance.fr/regions/grand-est/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-grand-est
2025
France
technical report
appraiser
Air Quality
prion diseases
health
air pollution, indoor
Respect
quality improvement
air, nos

---
https://www.santepubliquefrance.fr/regions/hauts-de-france/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-hauts-de-france
2025
France
technical report
Air Quality
appraiser
Respect
health
air pollution, indoor
air, nos
quality improvement
france
french

---
https://www.santepubliquefrance.fr/regions/normandie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-normandie
2025
France
technical report
health
air pollution, indoor
Air Quality
appraiser
air, nos
quality improvement
Respect

---
https://www.santepubliquefrance.fr/regions/nouvelle-aquitaine/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-nouvelle-aquitaine
2025
France
technical report
Air Quality
health
air, nos
quality improvement
air pollution, indoor
Respect
appraiser

---
https://www.santepubliquefrance.fr/regions/occitanie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-occitanie
2025
France
technical report
Respect
appraiser
quality improvement
air, nos
health
Air Quality
air pollution, indoor

---
https://www.santepubliquefrance.fr/regions/pays-de-la-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-pays-de-la-loire
2025
France
technical report
quality improvement
appraiser
air pollution, indoor
Respect
Air Quality
air, nos
health

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-corse
2025
France
technical report
appraiser
air pollution, indoor
corsica
Air Quality
Respect
france
health
quality improvement
air, nos

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-provence-alpes-cote-d-azur
2025
France
technical report
quality improvement
air pollution, indoor
health
appraiser
air, nos
unilateral
Respect
ribs
Air Quality

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_4.html
2025
France
journal article
malignant neoplasm colon/rectum
Respect
france
french
Colorectal Cancer
insurance coverage
colorectal neoplasms
early detection of cancer
screening for cancer
cancer screening
appraiser

---
https://kce.fgov.be/fr/publications/tous-les-rapports/developpement-academique-de-medicaments-de-therapie-innovante-atmp-en-belgique-considerations
2025
Belgium
technical report
french abstract
drug, nos
Drug Development
innovative therapies
belgium
Academia
academies
therapy, nos
academies and institutes
drug therapy
therapies, investigational

---
https://minerva-ebp.be/FR/Article/2418
2025
Belgium
critical appraisal or critical reading
thrombolysis
mechanical thrombolysis
cerebrovascular accident, nos
thrombolysis, nos
removal of thrombus, nos
association
lumen of vein
catheterization, central venous
snacks
stroke
thrombectomy

---
https://minerva-ebp.be/FR/Article/2421
2025
Belgium
critical appraisal or critical reading
counseling
treatment outcome
placebos
orthotic devices
exercise
Treatment Efficacy

---
Nous contacter.
12/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.